Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean A Virani

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Canadian Journal of Cardiology|July 8, 2018
Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation FormulaeJason G Andrade, Nathaniel M Hawkins, Christopher B Fordyce, et al.
CJC Open|March 2, 2026
Erratum: Author Corrections to "The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-Analysis [CJC Open. Volume 7, Issue 10, Pages 1332-1344. doi:10.1016/j.cjco.2025.05.021]"Christopher De Luca, Hardik Bhatt, Arnav Gupta, et al.
CJC Open|November 3, 2025
The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-AnalysisChristopher De Luca, Hardik Bhatt, Arnav Gupta, et al.
The Canadian Journal of Cardiology|May 15, 2020
Optimizing Access to Heart Failure Care in Canada During the COVID-19 PandemicSean A Virani, Brian Clarke, Anique Ducharme, et al.
Circulation. Heart Failure|April 6, 2024
Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart FailureRicky D Turgeon, Saranee Fernando, Marc Bains, et al.
Journal of the American College of Cardiology|July 2, 2021
Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the WeekMarat Fudim, Husam M Salah, Janarthanan Sathananthan, et al.
JACC. Heart Failure|February 2, 2023
Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure HospitalizationNima Moghaddam, Nathaniel M Hawkins, Robert McKelvie, et al.
CJC Open|March 12, 2020
Interdisciplinary Approach to an Unusual Case of Myocarditis in PregnancyAude Marceau, Justin M McGinnis, Fatemeh Derakhshan, et al.
Breast Cancer Research and Treatment|November 8, 2017
The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCTAmy A Kirkham, Neil D Eves, Rob E Shave, et al.
CJC Open|August 29, 2022
The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based TherapiesStephanie Poon, Benjamin Leis, Laurie Lambert, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Canadian Journal of Cardiology|July 8, 2018
Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation FormulaeJason G Andrade, Nathaniel M Hawkins, Christopher B Fordyce, et al.
CJC Open|March 2, 2026
Erratum: Author Corrections to "The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-Analysis [CJC Open. Volume 7, Issue 10, Pages 1332-1344. doi:10.1016/j.cjco.2025.05.021]"Christopher De Luca, Hardik Bhatt, Arnav Gupta, et al.
CJC Open|November 3, 2025
The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-AnalysisChristopher De Luca, Hardik Bhatt, Arnav Gupta, et al.
The Canadian Journal of Cardiology|May 15, 2020
Optimizing Access to Heart Failure Care in Canada During the COVID-19 PandemicSean A Virani, Brian Clarke, Anique Ducharme, et al.
Circulation. Heart Failure|April 6, 2024
Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart FailureRicky D Turgeon, Saranee Fernando, Marc Bains, et al.
Journal of the American College of Cardiology|July 2, 2021
Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the WeekMarat Fudim, Husam M Salah, Janarthanan Sathananthan, et al.
JACC. Heart Failure|February 2, 2023
Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure HospitalizationNima Moghaddam, Nathaniel M Hawkins, Robert McKelvie, et al.
CJC Open|March 12, 2020
Interdisciplinary Approach to an Unusual Case of Myocarditis in PregnancyAude Marceau, Justin M McGinnis, Fatemeh Derakhshan, et al.
Breast Cancer Research and Treatment|November 8, 2017
The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCTAmy A Kirkham, Neil D Eves, Rob E Shave, et al.
CJC Open|August 29, 2022
The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based TherapiesStephanie Poon, Benjamin Leis, Laurie Lambert, et al.
Pageof 5